FDA: Invokana May Cause Dangerous Blood Acid Levels

The U.S. Food and Drug Administration (FDA), is advising patients that the diabetes drug Invokana, as well as other SGLT2 inhibitors, may lead to diabetic ketoacidosis, or dangerously high blood acid levels. The agency cautions that this condition could require hospitalization and may even lead to complications such as coma or death, a Mississippi Invokana attorney notes.

If you or a loved one suffered complications after taking Invokana, contact Attorney Group for Mississippi today to discuss your options in a free, confidential, no-obligation consultation. We can answer your questions, and if you decide to pursue a claim for compensation, we can connect you with an affiliated Invokana lawsuit attorney who can assist you throughout the legal process.

The time you have to pursue a claim is limited. Contact us for more information.Get Help Now.

FDA Cautions Invokana Users To Be On Alert For Symptoms of Ketoacidosis

The FDA has issued a warning to patients who take Invokana to manage their blood sugar levels, citing the possible connection between this medication and other SGLT2 inhibitors and diabetic ketoacidosis. According to the FDA, in more than 20 known cases, patients taking Invokana or other diabetes drugs that belong to the same class developed diabetic ketoacidosis, a condition that involves excessive production and buildup of ketones in the blood. In the first 20 cases reported to the FDA, every patient required hospitalization for this potentially life-threatening condition.

Diabetic ketoacidosis typically affects people with Type I diabetes and high blood sugar levels, but the reported cases all involved Type 2 diabetics with slightly elevated blood sugar levels. The FDA has identified several possible precipitating factors, including serious illness and reductions in food, fluid or insulin intake. Given the grave potential effects of diabetic ketoacidosis, the FDA recommends that patients taking Invokana and similar drugs remain alert to common symptoms, such as exhaustion, difficulty breathing, abdominal pain, vomiting and disorientation, and seek immediate medical attention if these symptoms develop.

Injured Patients May Be Entitled to Compensation

Drug manufacturers have a duty to ensure their products are accompanied by full and accurate instructions and warnings to guide prescribing doctors and other health care providers in making treatment decisions. If a drug maker fails to fulfill this duty, it could be held liable in lawsuits for injuries that may result.

Patients who have been injured by Invokana may be entitled to compensation for damages, including:

  • Medical expenses
  • Pain, suffering, and mental anguish
  • Loss of income or ability to work

If a patient dies from complications after taking Invokana, his or her family members may be able to pursue claims for their loved one’s wrongful death. Compensation may include:

  • Pain, suffering, and mental anguish from the loss of a loved one
  • Loss of financial support of a loved one
  • Funeral expenses

Affected patients are encouraged to speak with a Mississippi Invokana attorney to learn more about their rights and remedies.

Contact Us For More Information

If you or a loved one took Invokana and suffered complications, contact Attorney Group for Mississippi for more information. You can fill out the form on this page, call us at the number listed at the top of the page, or email us at info@attorneygroup.com.

When you contact us, an attorney will follow up with you to speak with you about your case or answer questions that you might have. There is no cost or obligation to speak with us, and any information you provide will be kept confidential.

Please note that the law limits the time you have to pursue a claim for an injury. If you think you have a case, you should not delay taking action.

See our Frequently Asked Questions page for more information, and contact Attorney Group for Mississippi today.

Comments